Timapiprant, also known as OC000459, is a potent, selective and orally active CRTH2 antagonist. OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. OC000459 inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. OC000459 treatment inhibited LAR and post-allergen increase in sputum eosinophils. OC000459 appears to inhibit allergic inflammation in asthma.
Properties:
Density: 1.297 g/cm3
Boiling Point: 574.416ºC at 760 mmHg
Flash Point: 301.196ºC
GPR Inhibitors Related Prodcuts:
JMS-17-2; GSK137647A; CID 1375606; APD668